All News

Filter by

News Type
Topic
Language
Published Date

Filter by News Type

Done

Filter by Topic

Done

Filter by Language

Done

Filter by Published Date

Done
|
Media Availability
WHAT: A scientist from the National Institutes of Health will present promising, early results from a human clinical trial testing a novel gene replacement therapy in people with severe sickle cell disease. Preliminary findings suggest that the approach has an acceptable level of safety and might help patients consistently produce normal red blood...
A healthcare provider examines a chest x-ray to look for signs of COPD or other problems with the lungs.
|
Statement
On November 21, World COPD Day 2018, the National Institutes of Health unites with millions of people to renew our long-standing commitment to reducing the burden of chronic obstructive pulmonary disease ( COPD ), a serious and debilitating lung disease. A leading cause of death, COPD impacts an estimated 251 million people worldwide . While many h...
Illustration of woman sleeping
|
Research Features
Feeling sleepy during the day? You’re not alone. Insufficient sleep is a common and fast-growing problem, with almost a third of U.S. adults reporting they get less than the recommended amount of shuteye. But while some people experience occasional restless nights that still allow them to be alert and productive during the day, many others experien...
|
NHLBI in the Press
A new NHLBI-funded study showed that a change in the type of breathing tube paramedics use to resuscitate patients with sudden cardiac arrest can significantly improve the odds of survival and save thousands of lives. More than 90 percent of Americans who experience sudden cardiac arrest die before,
|
Statement
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, is pausing the CONCERT-HF trial , which involves patients with chronic heart failure. Recent calls for the retraction of journal articles in related fields of cell therapy research have raised concerns about the scientific foundations of this trial. Wh...
|
NHLBI in the Press
Researchers funded by NHLBI have performed prenatal gene editing to prevent a lethal congenital metabolic disease in mice. The study findings, published in Nature Medicine, offer proof of concept for the possibility of genetic therapies before birth.